Skip to main content

Celldex Therapeutics, Inc 10-Q for FY2022 Q1

Celldex Therapeutics, Inc. (CLDX)

10-Q 2022-05-05 For: 2022-03-31
View Original
Added on April 04, 2026

About this 10-Q

Celldex Therapeutics, Inc filed this 10-Q on May 5, 2022, covering the quarter ended March 31, 2022 (FY2022 Q1).

Headline figures

Quarter ended March 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$174K
down 74.6% from $685K a year earlier
Diluted EPS
-$0.49
compared with -$0.42 a year earlier